Prolia works similarly to alendronate by slowing down the cells that break down bone, called osteoclasts. Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so ...

Investigators evaluated the long-term impact of taxane chemotherapy on patient-reported neuropathy, balance problems, and falls among older breast cancer survivors.

Through a donor-funded Hospital at Home program at Alberta Children’s Hospital, specialized oncology nurses delivered some ...

As Jessica Huffman underwent a double mastectomy and chemotherapy for invasive breast cancer two years ago, she felt mostly normal for most of the treatment. The exception was the loss of her long ...

Ron Duguay has a new pep in his step. The Rangers legend, who recently revealed that he’s been battling Stage 4 colon cancer, just received much-needed good news. After a visit with his doctor at City ...

The content creator, 26, was diagnosed with a rare bile duct cancer nearly three years ago ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...

Breakthrough immunotherapy trials are showing unprecedented responses in a subset of rectal cancer patients, hinting at a ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...